Choosing, Selecting, and Managing Your External Sourcing Partners
Posted on September 2, 2015
By: Firelli Alonso-Caplen, Ph.D.
Senior Director, Pharmaceutical Sciences, Biotheraputics & Vaccines Outsourcing
Worldwide Research & Development
Pfizer Inc.
An increasing number of biopharmaceutical and biotechnological companies currently depend on Contract Development & Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs) for the development and manufacture of biological Drug Substance (DS) and Drug Product (DP). It ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Adaptability, Biopharmaceutical Industry, CDMOs, chemistry, Choosing, CMC, CMOs, collaborative manufacturing, Contract Development & Manufacturing Organizations, Contract Manufacturing Organizations, Controls, Cost, DP, Drug Product, drug substance, DS, External Sourcing Partners, Externalization, externalization strategies, Firelli Alonso-Caplen, Flexibility, Guiding Principles, manufacturing, mergers and acquisitions, Outsourcing, quality, Risk, Selecting, Time, Worldwide Research and Development
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
